These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 24724402

  • 21. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease.
    Küppers R, Rajewsky K.
    Annu Rev Immunol; 1998; 16():471-93. PubMed ID: 9597138
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma.
    Schmitz R, Stanelle J, Hansmann ML, Küppers R.
    Annu Rev Pathol; 2009; 4():151-74. PubMed ID: 19400691
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Hodgkin lymphoma. Classification and pathogenesis].
    Foss HD, Marafioti T, Stein H.
    Pathologe; 2000 Mar; 21(2):113-23. PubMed ID: 10840817
    [Abstract] [Full Text] [Related]

  • 29. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS, Said JW.
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [Abstract] [Full Text] [Related]

  • 30. Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma.
    Claesson HE, Griffiths WJ, Brunnström A, Schain F, Andersson E, Feltenmark S, Johnson HA, Porwit A, Sjöberg J, Björkholm M.
    FEBS J; 2008 Aug; 275(16):4222-34. PubMed ID: 18647347
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hodgkin's lymphoma: molecular targets and novel treatment strategies.
    Yazbeck V, Georgakis GV, Wedgwood A, Younes A.
    Future Oncol; 2006 Aug; 2(4):533-51. PubMed ID: 16922620
    [Abstract] [Full Text] [Related]

  • 40. Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies.
    Stein H, Hummel M.
    Semin Hematol; 1999 Jul; 36(3):233-41. PubMed ID: 10462323
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.